Cargando…
Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak
Clinical and model studies indicate that low nitric oxide (NO) bioavailability due in part to profound hypoargininemia contributes to cerebral malaria (CM) pathogenesis. Protection against CM pathogenesis may be achieved by altering the diet before infection with Plasmodium falciparum infection (nut...
Autores principales: | Gramaglia, Irene, Velez, Joyce, Chang, Yu-Sun, Caparros-Wanderley, Wilson, Combes, Valery, Grau, Georges, Stins, Monique F., van der Heyde, Henri C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407779/ https://www.ncbi.nlm.nih.gov/pubmed/30849122 http://dx.doi.org/10.1371/journal.pone.0213428 |
Ejemplares similares
-
Reduced erythrocyte deformability associated with hypoargininemia during Plasmodium
falciparum malaria
por: Rey, Juliana, et al.
Publicado: (2014) -
Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
por: Cloots, Roy H. E., et al.
Publicado: (2018) -
Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria
por: El-Assaad, Fatima, et al.
Publicado: (2014) -
Citrulline in the management of patients with urea cycle disorders
por: Imbard, Apolline, et al.
Publicado: (2023) -
Inhibition of Endothelial Activation: A New Way to Treat Cerebral Malaria?
por: Wassmer, Samuel C, et al.
Publicado: (2005)